# A Food-Effect Study of BPI-16350 in Healthy Subjects

> **NCT05316259** · PHASE1 · COMPLETED · sponsor: **Betta Pharmaceuticals Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BPI-16350

## Key facts

- **NCT ID:** NCT05316259
- **Lead sponsor:** Betta Pharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-15
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316259, "A Food-Effect Study of BPI-16350 in Healthy Subjects". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05316259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
